Y chromosome loss found in healthy tissue near tumours in 11 organs

Men lose the Y chromosome from some of their cells as they age. That much has been known for decades and was treated as a harmless artefact of getting older. A study out of the University of Arizona Cancer Center, published in JCI Insight, argues it is not harmless.

The team, led by Dr Dan Theodorescu, examined about 1,000 tissue samples from 405 men, running automated fluorescent imaging across more than 4.3 million cell nuclei. They found Y chromosome loss in normal-looking tissue sitting next to tumours, across 11 major organs.

Why that detail matters

Finding a genetic change inside a tumour tells you what the cancer looks like. Finding it in healthy tissue beside the tumour raises the possibility that it came first.

"That finding is what makes this discovery so exciting," Theodorescu said. "It suggests we may be looking at one of the earliest signposts of cancer forming."

The loss showed up most often in normal-looking tissue around colon, rectal, oesophageal, pancreatic and lung cancers. In bladder tissue the team mapped the progression in detail, following Y chromosome loss from normal tissue through to cancerous tissue.

What this does not mean

This is an association found in tissue samples, not a test you can ask for and not a treatment. Losing the Y chromosome in some cells does not mean a man has cancer or will get it. The study's value is that it points pathologists at a place to look earlier, and it gives researchers a candidate marker to test properly in larger prospective studies.

Nothing here changes screening advice. The cancers involved, particularly colorectal and lung, already have established screening and risk-reduction routes, and smoking remains the single largest modifiable risk for several of them.

The Pakistani context

Pakistan has no national cancer registry covering the whole population, which makes incidence figures here estimates rather than counts. Oral, lung, breast and liver cancers dominate the case load reported by the large treating centres. The practical bottleneck is not marker discovery, it is that most patients arrive at a late stage.

If a man in his sixties reads this and takes one thing from it, the useful action is a colonoscopy conversation with a doctor, not a genetic test. Our directory of hospitals lists the major treating centres by city.